Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00831935 · ClinicalTrials.gov registry record
Use of Conversation and Acoustic Signals in Measuring Depression Severity
A clinical trial of Depression, sponsored by Boston Medical Center.
- Completed
- Registry status
- 89
- Enrollment target
- 2
- Study locations
NCT00831935: Completed study of Depression, sponsored by Boston Medical Center.
NCT00831935 is a study of Depression that has completed, run by Boston Medical Center. The registered enrollment target is 89 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00831935, a study of Depression, has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- 89 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to test a new monitoring technology that uses the sound of a depressed person's speech to assess the severity of depression symptoms. The Vocal Social Signals Platform (VSSP) is software that analyzes the non-verbal characteristics of a person's speech. This study will test this software to see if it could be a useful measurement tool for assessing depression symptoms. Participation in this study requires coming to the research headquarters twice over a three-month period. The first visit is to determine eligibility. Throughout the study, participants will be connected to a telephone system five times, on which they will answer questions about their depression symptoms. After answering questions, their voice will be recorded using a structured speech sample that the participant will read out loud. The participant will also give an unstructured speech sample, which will involve describing a typical day or the last movie s/he saw. The voice samples will be analyzed and compared to the results of the depression symptom questionnaires.
Conditions Studied
Study Locations (2)
Massachusetts
- Boston Medical Center - Boston
- Boston University Medical Campus - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2009-01 |
| Est. Completion | 2011-06 |
What the finished NCT00831935 record still lists
NCT00831935 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 89 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 0 interventions.
NCT00831935 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00831935 about?
NCT00831935 is a clinical study titled "Use of Conversation and Acoustic Signals in Measuring Depression Severity". The purpose of this study is to test a new monitoring technology that uses the sound of a depressed person's speech to assess the severity of depression symptoms. The Vocal Social Signals Platform (VSSP) is software that analyzes the non-verbal characteristics of a person's speech. This study will t...
What is the current status of trial NCT00831935?
This trial is currently completed. The enrollment target is 89 participants. The study started on 2009-01. Estimated completion is 2011-06.
What conditions does trial NCT00831935 study?
This clinical trial studies the following conditions: Depression.
Who is sponsoring clinical trial NCT00831935?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00831935 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00831935's enrollment target sits among peer trials
89 361st of 679 higher than 318 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Depression and Driving
RECRUITING
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
RECRUITING · Phase 1
-
Identifying and Treating Depression in the Orthopaedic Trauma Population
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03682289 · 89 participants · Phase 2
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
- NCT04787939 · 89 participants · NA
Early Feeding After Oral Cavity Reconstruction
- NCT05480449 · 89 participants · Phase 1
Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)
- NCT05604131 · 89 participants · Phase 2
Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia